Isolated limb infusion for melanoma: a less morbid alternative to hyperthermic isolated limb perfusion in the US

被引:2
作者
Santillan, Alfredo A. [1 ]
Zager, Jonathan S. [2 ]
机构
[1] Univ Texas Hlth Sci Ctr San Antonio, Sect Surg Oncol, Dept Surg, Audie L Murphy Vet Affairs Hosp, San Antonio, TX 78229 USA
[2] Univ S Florida, Dept Oncol Sci & Surg, Tampa, FL 33612 USA
关键词
melanoma; melphalan; regional arterial infusion; toxicity; ACUTE REGIONAL TOXICITY; TUMOR-NECROSIS-FACTOR; MELPHALAN; EXPERIENCE; CHEMOTHERAPY; EXTREMITY; TRIAL;
D O I
10.1517/17425250903559881
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
引用
收藏
页码:1033 / 1037
页数:5
相关论文
共 21 条
  • [1] An evidence-based staging system for cutaneous melanoma
    Balch, CM
    Soong, SJ
    Atkins, MB
    Buzaid, AC
    Cascinelli, N
    Coit, DG
    Fleming, ID
    Gershenwald, JE
    Houghton, A
    Kirkwood, JM
    McMasters, KM
    Mihm, MF
    Morton, DL
    Reintgen, DS
    Ross, MI
    Sober, A
    Thompson, JA
    Thompson, JF
    [J]. CA-A CANCER JOURNAL FOR CLINICIANS, 2004, 54 (03) : 131 - 149
  • [2] Isolated limb infusion for in-transit malignant melanoma of the extremity: A well-tolerated but less effective alternative to hyperthermic isolated limb perfusion
    Beasley, Georgia M.
    Petersen, Rebecca P.
    Yoo, Jin
    McMahon, Nicole
    Aloia, Thomas
    Petros, William
    Sanders, Gretchen
    Cheng, Tsung-Yen
    Pruitt, Scott K.
    Seigler, Hilliard
    Tyler, Douglas S.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2008, 15 (08) : 2195 - 2205
  • [3] A Multi-Institutional Experience of Isolated Limb Infusion: Defining Response and Toxicity in the US
    Beasley, Georgia M.
    Caudle, Abigail
    Petersen, Rebecca P.
    McMahon, Nicole S.
    Padussis, James
    Mosca, Paul J.
    Zager, Jonathan S.
    Hochwald, Steven N.
    Grobmyer, Stephen R.
    Delman, Keith A.
    Andtbacka, Robert H.
    Noyes, R. Dirk
    Kane, John M.
    Seigler, Hilliard
    Pruitt, Scott K.
    Ross, Merrick I.
    Tyler, Douglas S.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2009, 208 (05) : 706 - 715
  • [4] A phase II trial of isolated limb infusion with melphalan and dactinomycin for regional melanoma and soft tissue sarcoma of the extremity
    Brady, Mary S.
    Brown, Karen
    Patel, Ami
    Fisher, Charles
    Marx, Will
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2006, 13 (08) : 1123 - 1129
  • [5] Randomized multicenter trial of hyperthermic isolated limb perfusion with melphalan alone compared with melphalan plus tumor necrosis factor: American College of Surgeons Oncology Group trial Z0020
    Cornett, Wendy R.
    McCall, Linda M.
    Petersen, Rebecca P.
    Ross, Merrick I.
    Briele, Henry A.
    Noyes, R. Dirk
    Sussman, Jeffrey J.
    Kraybill, William G.
    Kane, John M., III
    Alexander, H. Richard
    Lee, Jeffrey E.
    Mansfield, Paul F.
    Pingpank, James F.
    Winchester, David J.
    White, Richard L., Jr.
    Chadaram, Vijaya
    Herndon, James E., II
    Fraker, Douglas L.
    Tyler, Douglas S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (25) : 4196 - 4201
  • [6] CHEMOTHERAPY OF CANCER - REGIONAL PERFUSION UTILIZING AN EXTRACORPOREAL CIRCUIT
    CREECH, O
    KREMENTZ, ET
    RYAN, RF
    WINBLAD, JN
    [J]. ANNALS OF SURGERY, 1958, 148 (04) : 616 - 632
  • [7] KLAASE JM, 1994, SURGERY, V115, P39
  • [8] REGIONAL CHEMOTHERAPY FOR MELANOMA - A 35-YEAR EXPERIENCE
    KREMENTZ, ET
    CARTER, RD
    SUTHERLAND, CM
    MUCHMORE, JH
    RYAN, RF
    CREECH, O
    [J]. ANNALS OF SURGERY, 1994, 220 (04) : 520 - 535
  • [9] Outcomes Following Isolated Limb Infusion for Melanoma. A 14-Year Experience
    Kroon, Hidde M.
    Moncrieff, Marc
    Kam, Peter C. A.
    Thompson, John F.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2008, 15 (11) : 3003 - 3013
  • [10] Factors Predictive of Acute Regional Toxicity After Isolated Limb Infusion with Melphalan and Actinomycin D in Melanoma Patients
    Kroon, Hidde M.
    Moncrieff, Marc
    Kam, Peter C. A.
    Thompson, John F.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2009, 16 (05) : 1184 - 1192